WCG Report: 92% of Clinical Trial Organizations Plan AI Investment Within Two Years
· Source: clinicaltrialvanguard.com
In short
WCG's 2026 Clinical Research Trends and Insights Report reveals that while only about one-third of organizations currently use AI across a meaningful share of their clinical trials, 92% plan to increase AI investment within the next two years. The report highlights four operational priorities: AI and machine learning integration, site and investigator readiness, participant experience, and cell and gene therapy logistics. It also emphasizes the need for governance and auditability as AI moves from experimental pilots into embedded trial operations.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 30, 2026: AI Integration Drives Real-Time Gains in Supply Chain Execution and Productivity
Tags: clinical trials, AI, machine learning, site readiness, regulatory, investment